Beckman Coulter, Inc. · Class II · Cleared Jul 3, 2024
| K-number | K240996 |
| Device name | Access Thyroglobulin Antibody II |
| Applicant | Beckman Coulter, Inc. |
| Product code | JNL |
| Device class | Class II |
| Decision date | Jul 3, 2024 |
| Decision | Substantially Equivalent |
| Regulation | 866.5870 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov